<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02312362</url>
  </required_header>
  <id_info>
    <org_study_id>HFDS_PS_v9</org_study_id>
    <nct_id>NCT02312362</nct_id>
  </id_info>
  <brief_title>High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP</brief_title>
  <acronym>HFDS_abinterno</acronym>
  <official_title>HFDS ab Interno - to Compare Intraocular Pressure (IOP) Lowering Effect of Combined High Frequency Deep Sclerotomy ab Interno (HFDS ab Interno) With Phacoemulsification and Phacoemulsification Alone, in Primary Open Angle Glaucoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oertli Instrumente AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Geneva, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oertli Instrumente AG</source>
  <brief_summary>
    <textblock>
      Objective:

      To compare intraocular pressure lowering effect of combined sclerotomy ab interno with
      phacoemulsification and phacoemulsification alone, in primary or secondary open angle
      glaucoma patients.

      Study design:

      Prospective, randomized, case- control interventional surgical trial
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>Baseline screening till 3 year post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>visual acuity</measure>
    <time_frame>Baseline screening till 3 year post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>decrease in anti glaucoma medications</measure>
    <time_frame>Baseline screening till 3 year post-op</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Cataract</condition>
  <condition>Glaucoma</condition>
  <condition>POAG</condition>
  <arm_group>
    <arm_group_label>Combined sclerotomy ab interno and phaco</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined sclerotomy ab interno and phacoemulsification with IOL implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phacoemulsification with IOL implantation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phacoemulsification with IOL implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined sclerotomy ab interno and phaco</intervention_name>
    <arm_group_label>Combined sclerotomy ab interno and phaco</arm_group_label>
    <other_name>High Frequency Deep Sclerotomy (=HFDS)</other_name>
    <other_name>HFDS</other_name>
    <other_name>STT (formerly)</other_name>
    <other_name>abee tip</other_name>
    <other_name>Cataract surgery combined with HFDS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification with IOL implantation</intervention_name>
    <arm_group_label>Phacoemulsification with IOL implantation</arm_group_label>
    <other_name>Phacoemulsification</other_name>
    <other_name>Phaco</other_name>
    <other_name>Cataract Surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients suffering from primary open-angle glaucoma (POAG) inadequately controlled with
        maximum tolerated medical therapy and who will be treated with cataract surgery.

        Exclusion Criteria:

          -  One eyed patients

          -  Unwilling or unable to give consent, unwilling to accept randomization, or unable to
             return for scheduled protocol visits

          -  The presence of extreme narrow angle with complete or partial closure in either eye,
             except for occludable angles treated with a patent iridectomy

          -  Any abnormality preventing reliable applanation tonometry, any opacity or patient
             uncooperativeness that would restrict adequate examination of the ocular fundus or
             anterior chamber of either eye

          -  The risk of visual field or visual acuity worsening as a consequence of participation
             in the trial, in the investigator's opinion

          -  Any clinically significant, serious, or severe medical or psychiatric condition; any
             condition that, in the investigator's opinion, would interfere with optimal
             participation in the study or present a special risk to the patient

          -  Participation in any other investigational study within 30 days prior to baseline
             visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farhad Hafezi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Geneva, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lothar Knuenz</last_name>
    <email>lothar.knuenz@oertli-instruments.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Aswan</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Reinach</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
    <country>Germany</country>
    <country>India</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Pajic B, Pajic-Eggspuehler B, Haefliger I. New minimally invasive, deep sclerotomy ab interno surgical procedure for glaucoma, six years of follow-up. J Glaucoma. 2011 Feb;20(2):109-14. doi: 10.1097/IJG.0b013e3181dddf31.</citation>
    <PMID>20520572</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2014</study_first_posted>
  <last_update_submitted>December 5, 2014</last_update_submitted>
  <last_update_submitted_qc>December 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HFDS</keyword>
  <keyword>ab interno</keyword>
  <keyword>MIGS</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

